𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chronic hepatitis B: Update 2009

✍ Scribed by Anna S. F. Lok; Brian J. McMahon

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
51 KB
Volume
50
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Chronic hepatitis B: Update of recommend
Chronic hepatitis B: Update of recommendations
✍ Anna S.F. Lok; Brian J. McMahon πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 92 KB

A n estimated 350 million persons worldwide and 1.25 million in the United States are infected with hepatitis B virus (HBV). Hepatitis B carriers are at risk for development of cirrhosis and hepatocellular carcinoma (HCC). The natural history of chronic HBV infection is variable. Persons with chroni

Treatment of chronic hepatitis B
Treatment of chronic hepatitis B
✍ Gary L. Davis πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 365 KB

Treatment of Chronic Hepatitis B Chronic HBV infection is common and affects more than 200 million individuals worldwide. It is estimated that more than 1 million persons in the United States alone are Chronically infected with this virus. Fur-

Tenofovir in chronic hepatitis B
Tenofovir in chronic hepatitis B
✍ P. Del Poggio; C. Jamoletti; M. Zaccanelli πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 65 KB

We have read with interest the article of Dr. Fartoux and colleagues, 1 who assessed the factors involved in the progression of fibrosis in 135 mild chronic hepatitis C (CHC) patients who underwent paired liver biopsies after a median of 61 months. Steatosis was the only determinant of fibrosis prog

Hepatitis B virus DNA prediction rules f
Hepatitis B virus DNA prediction rules for hepatitis B e antigen–negative chronic hepatitis B
✍ Jordan J. Feld; Melissa Ayers; Dahlia El-Ashry; Tony Mazzulli; Raymond Tellier; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English

After hepatitis B e antigen (HBeAg) seroconversion, hepatitis B may become inactive or progress to HBeAg-negative hepatitis with persistent or intermittent alanine aminotransferase (ALT) elevation. The aim of this study was to prospectively identify factors predictive of the clinical course in HBeAg

Hepatitis B virus DNA levels and outcome
Hepatitis B virus DNA levels and outcomes in chronic hepatitis B
✍ Chien-Jen Chen; Hwai-I Yang; Uchenna H. Iloeje; The REVEAL-HBV Study Group πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 265 KB πŸ‘ 2 views

Serum hepatitis B virus (HBV) DNA levels can fluctuate markedly during the course of chronic HBV infection. Both case-control and cohort studies have shown a significant, dose-response association between serum HBV DNA levels measured at the time of initial evaluation and the subsequent risk of cirr